NRC Health reported results for the quarter ended 2026 with revenue of $35.39M, up 4% from $34.04M a year earlier, and a net loss of ($3.28M) versus a loss of ($106K) in the prior-year quarter; diluted EPS was ($0.15) compared with ($0.01) a year ago.Financial Highlights¹ Reported as “Revenue”. ² R…
NRC Health reported second-quarter 2026 results with Total Recurring Contract Value (TRCV) rising 11% year-over-year to $151.9 million and total revenue of $35.4 million, up 4% from the prior year. GAAP net loss for the quarter was $3.3 million, while Adjusted Net Income was $6.9 million, correspon…
Q2 2026 saw 11% TRCV growth and 4% revenue growth year-over-year, with Adjusted Net Income at $6.9 million and Adjusted EBITDA margin at 27%. The company declared a $0.16 dividend and is positioned for a strong second half of 2026.Original document: NRC Health [NRC] SEC 8-K Current Report — Jul. 28…
NRC (NRC Health) is set to announce its Q2'26 results on July 28, after the market closes. The earnings are expected to be disclosed at 4:00 PM ET (8:00 PM UTC).For Q2'26, revenue estimate is 34.90 million USD with EPS (earnings per share) anticipated at (0.15) USD. Learn more details at NRC Financ…
